Etoricoxib is a potent cyclooxygenase-2 (COX-2) inhibitor used to treat rheumatoid arthritis. In a 12-week trial, etoricoxib (90 mg once daily) was found to be more effective in treating rheumatoid arthritis than naproxen (500 mg twice daily) or placebo.